Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination ; volume:23 ; number:1 ; day:5 ; month:6 ; year:2024 ; pages:1-11 ; date:12.2024
Malaria journal ; 23, Heft 1 (5.6.2024), 1-11, 12.2024
- Urheber
-
Nguyen Ngoc Pouplin, Julie
Kaendiao, Thoopmanee
Rahimi, Bilal Ahmad
Soni, Mayur
Basopia, Hensi
Shah, Darshana
Patil, Jitendra
Dholakia, Vyom
Suthar, Yash
Tarning, Joel
Mukaka, Mavuto
Taylor, Walter R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12936-024-04947-6
- URN
-
urn:nbn:de:101:1-2408131124509.218562769859
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nguyen Ngoc Pouplin, Julie
- Kaendiao, Thoopmanee
- Rahimi, Bilal Ahmad
- Soni, Mayur
- Basopia, Hensi
- Shah, Darshana
- Patil, Jitendra
- Dholakia, Vyom
- Suthar, Yash
- Tarning, Joel
- Mukaka, Mavuto
- Taylor, Walter R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa
Formulation study of duloxetine hydrochloride enteric-coated tablets
Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
Formulation development, in vivo bioequivalence and pediatric PBPK modeling studies of taste-masked ciprofloxacin chewable tablets
Is it time for Africa to adopt primaquine in the era of malaria control and elimination?
Efficient model-based bioequivalence testing
The reality of using primaquine
Properties of paper coated with Prunus serotina (Ehrh.) extract formulation
Access to primaquine in the last mile: challenges at the service delivery points in pre-elimination era, Myanmar
Primaquine: the risks and the benefits
Novel formulation and processing aspects for compression coated tablets and for the compression of polymer-coated multiparticulates
Formulation and characterization of polyester-lignite composite coated slow-release fertilizers
Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa
Formulation study of duloxetine hydrochloride enteric-coated tablets
Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
Formulation development, in vivo bioequivalence and pediatric PBPK modeling studies of taste-masked ciprofloxacin chewable tablets
Is it time for Africa to adopt primaquine in the era of malaria control and elimination?
Efficient model-based bioequivalence testing
The reality of using primaquine
Properties of paper coated with Prunus serotina (Ehrh.) extract formulation
Access to primaquine in the last mile: challenges at the service delivery points in pre-elimination era, Myanmar
Primaquine: the risks and the benefits
Novel formulation and processing aspects for compression coated tablets and for the compression of polymer-coated multiparticulates
Formulation and characterization of polyester-lignite composite coated slow-release fertilizers
Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa
Formulation study of duloxetine hydrochloride enteric-coated tablets
Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
Formulation development, in vivo bioequivalence and pediatric PBPK modeling studies of taste-masked ciprofloxacin chewable tablets
Is it time for Africa to adopt primaquine in the era of malaria control and elimination?
Efficient model-based bioequivalence testing
The reality of using primaquine
Properties of paper coated with Prunus serotina (Ehrh.) extract formulation
Access to primaquine in the last mile: challenges at the service delivery points in pre-elimination era, Myanmar
Primaquine: the risks and the benefits
Novel formulation and processing aspects for compression coated tablets and for the compression of polymer-coated multiparticulates